{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T20:12:01Z","timestamp":1772568721794,"version":"3.50.1"},"reference-count":39,"publisher":"BMJ","issue":"e1","funder":[{"name":"Not funded"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2022,5,16]]},"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:p>The number of patients coming to hospital with liver disease is increasing. There was a worrying trend before the pandemic, and this has intensified. Despite improvements in the management of patients with advanced cirrhosis many patients will die within 6\u201312 months of first presentation, and, despite this, the field of palliative and supportive care in liver disease is still in its infancy. This is a narrative review. Evidence is often thin in this field. Where it exists it is cited, but much of the commentary here is based on the authors own experience and readers are free to consider it and debate it. Most patients who die of liver disease receive palliative care very late in their illness (if at all). There are many barriers to supportive and palliative care in liver disease which are discussed. Symptom control is often poor because of these barriers. Before symptomatic control can be established, patients in need of it must to be identified and conversations had about the severity of their situation and what their wishes would be. Interest in palliative and supportive care for patients liver disease is growing as is the number of hepatologists and palliative care clinicians within the UK with an interest. It is important that this enthusiasm and interest can be rolled out and scaled up across the UK so that all patients, wherever they are, can benefit. The aims of these articles are first to highlight and bring into focus the unmet need for palliative and supportive care in liver disease and second to provide suggestions for its integration into liver services. Ask yourself the question: where would I start in my hospital to help these patients?<\/jats:p>","DOI":"10.1136\/flgastro-2022-102114","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T13:28:42Z","timestamp":1654090122000},"page":"e109-e115","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Symptom control in advanced chronic liver disease: integrating anticipatory palliative and supportive care"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7046-241X","authenticated-orcid":false,"given":"Mark","family":"Wright","sequence":"first","affiliation":[{"name":"Hepatology, University Hospital Southampton, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazel","family":"Woodland","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Salisbury District Hospital, Salisbury, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Hudson","sequence":"additional","affiliation":[{"name":"Hepatology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"2025090708135267000_13.e1.e109.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32866-0"},{"key":"2025090708135267000_13.e1.e109.2","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1097\/MCG.0000000000001627","article-title":"The pandemic within the pandemic: unprecedented rise in alcohol-related hepatitis during the COVID-19 pandemic","volume":"56","author":"Sohal","year":"2022","journal-title":"J Clin Gastroenterol"},{"key":"2025090708135267000_13.e1.e109.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.024"},{"key":"2025090708135267000_13.e1.e109.4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL clinical practice guidelines: management of alcohol-related liver disease","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"2025090708135267000_13.e1.e109.5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"2025090708135267000_13.e1.e109.6","doi-asserted-by":"crossref","DOI":"10.1002\/hep.32378","article-title":"AASLD practice guidance: palliative care and symptom-based management in decompensated cirrhosis","author":"Rogal","year":"2022","journal-title":"Hepatology"},{"key":"2025090708135267000_13.e1.e109.7","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2019-101180"},{"key":"2025090708135267000_13.e1.e109.8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321790"},{"key":"2025090708135267000_13.e1.e109.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.019"},{"key":"2025090708135267000_13.e1.e109.10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jpainsymman.2020.12.007","article-title":"Palliative long-term abdominal drains versus large volume paracentesis in refractory ascites due to cirrhosis (reduce study): qualitative outcomes","volume":"62","author":"Cooper","year":"2021","journal-title":"J Pain Symptom Manage"},{"key":"2025090708135267000_13.e1.e109.11","doi-asserted-by":"crossref","first-page":"S-34","DOI":"10.1089\/jpm.2019.0121","article-title":"Introducing palliative care within the treatment of end-stage liver disease: the study protocol of a cluster randomized controlled trial","volume":"22","author":"Verma","year":"2019","journal-title":"J Palliat Med"},{"key":"2025090708135267000_13.e1.e109.12","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-018-2779-0","article-title":"Palliative long-term abdominal drains versus repeated drainage in individuals with untreatable ascites due to advanced cirrhosis: study protocol for a feasibility randomised controlled trial","volume":"19","author":"Macken","year":"2018","journal-title":"Trials"},{"key":"2025090708135267000_13.e1.e109.13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jpainsymman.2019.06.023","article-title":"COMPASS: a pilot trial of an early palliative care intervention for patients with end-stage liver disease","volume":"58","author":"Shinall","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"2025090708135267000_13.e1.e109.14","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jamainternmed.2021.0152","article-title":"Deficits in advance care planning for patients with decompensated cirrhosis at liver transplant centers","volume":"181","author":"Patel","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2025090708135267000_13.e1.e109.15","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.cgh.2019.03.022","article-title":"Barriers to use of palliative care and advance care planning discussions for patients with end-stage liver disease","volume":"17","author":"Ufere","year":"2019","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"2025090708135267000_13.e1.e109.16","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2014-307263.34","article-title":"OC-034\u2005Outcome Of Patients Considered Unsuitable For Liver Transplantation \u2013 A Missed Opportunity For Palliative Care?","volume":"63","author":"Phoolchund","year":"2014","journal-title":"Gut"},{"key":"2025090708135267000_13.e1.e109.17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cld.478","article-title":"Palliative care for patients with end-stage liver disease: an overview","volume":"6","author":"Rakoski","year":"2015","journal-title":"Clin Liver Dis"},{"key":"2025090708135267000_13.e1.e109.18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.cgh.2013.08.027","article-title":"Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management","volume":"12","author":"Poonja","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090708135267000_13.e1.e109.19","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jpainsymman.2015.07.014","article-title":"Benefit of early palliative care intervention in end-stage liver disease patients awaiting liver transplantation","volume":"50","author":"Baumann","year":"2015","journal-title":"J Pain Symptom Manage"},{"key":"2025090708135267000_13.e1.e109.20","doi-asserted-by":"crossref","unstructured":"Kimbell B , Murray SA , Byrne H . Palliative care for people with advanced liver disease: a feasibility trial of a supportive care liver nurse specialist. Palliat Med 2018;269216318760441.","DOI":"10.1177\/0269216318760441"},{"key":"2025090708135267000_13.e1.e109.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2011.10.018"},{"key":"2025090708135267000_13.e1.e109.22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009241","article-title":"Managing uncertainty in advanced liver disease: a qualitative, multiperspective, serial interview study: Table\u00a01","volume":"5","author":"Kimbell","year":"2015","journal-title":"BMJ Open"},{"key":"2025090708135267000_13.e1.e109.23","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2016-100734"},{"key":"2025090708135267000_13.e1.e109.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2013-000488"},{"key":"2025090708135267000_13.e1.e109.25","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/hep.31316","article-title":"Considerations for prognosis, goals of care, and specialty palliative care for hospitalized patients with Acute\u2010on\u2010Chronic liver failure","volume":"72","author":"Hernaez","year":"2020","journal-title":"Hepatology"},{"key":"2025090708135267000_13.e1.e109.26","article-title":"Early palliative care referral in patients with end stage liver disease is associated with reduced resource utilisation","author":"Barnes","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"2025090708135267000_13.e1.e109.27","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jpainsymman.2019.07.011","article-title":"Outcomes of palliative care consultations for hospitalized patients with liver disease","volume":"58","author":"Ufere","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"2025090708135267000_13.e1.e109.28","doi-asserted-by":"publisher","DOI":"10.1177\/0269216318807051"},{"key":"2025090708135267000_13.e1.e109.29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ajg.2017.443","article-title":"The liver frailty index improves mortality prediction of the subjective clinician assessment in patients with cirrhosis","volume":"113","author":"Lai","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2025090708135267000_13.e1.e109.30","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1097\/TP.0000000000001433","article-title":"Performance-Based measures associate with frailty in patients with end-stage liver disease","volume":"100","author":"Lai","year":"2016","journal-title":"Transplantation"},{"key":"2025090708135267000_13.e1.e109.31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S2468-1253(17)30362-X","article-title":"Cirrhosis with ascites in the last year of life: a nationwide analysis of factors shaping costs, health-care use, and place of death in England","volume":"3","author":"Hudson","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025090708135267000_13.e1.e109.32","unstructured":"British association for the study of the liver end of life special interest G. Available: https:\/\/www.basl.org.uk\/uploads\/End%20of%20Life%20SIG\/Symptom%20control%20in%20adults%20with%20advanced%20liver%20disease%20-%20BASL%20Final.pdf"},{"key":"2025090708135267000_13.e1.e109.33","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2016-100792"},{"key":"2025090708135267000_13.e1.e109.34","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819858256","article-title":"The efficacy and safety of rifaximin-\u03b1: a 2-year observational study of overt hepatic encephalopathy","volume":"12","author":"Oey","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"key":"2025090708135267000_13.e1.e109.35","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/apt.14950","article-title":"Randomised clinical trial: oral taurine supplementation versus placebo reduces muscle cramps in patients with chronic liver disease","volume":"48","author":"Vidot","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090708135267000_13.e1.e109.36","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-012-0632-x"},{"key":"2025090708135267000_13.e1.e109.37","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S2468-1253(21)00169-2","article-title":"Sleep and liver disease: a bidirectional relationship","volume":"6","author":"Marjot","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025090708135267000_13.e1.e109.38","unstructured":"Liver Frailty Index\u2122. Available: https:\/\/liverfrailtyindex.ucsf.edu\/"},{"key":"2025090708135267000_13.e1.e109.39","doi-asserted-by":"crossref","first-page":"920-930","DOI":"10.1002\/hep4.1849","article-title":"Palliative care always: Hepatology-Virtual primary palliative care training for Hepatologists","volume":"6","author":"DeNofrio","year":"2022","journal-title":"Hepatol Commun"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2022-102114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:14:01Z","timestamp":1757258041000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2022-102114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":39,"journal-issue":{"issue":"e1","published-online":{"date-parts":[[2022,6,20]]},"published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.1136\/flgastro-2022-102114"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2022-102114","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"value":"2041-4137","type":"print"},{"value":"2041-4145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}